메뉴 건너뛰기




Volumn 40, Issue 2, 2014, Pages 443-454

Accuracy of cerebrospinal fluid Aβ1-42 for Alzheimer's disease diagnosis: A systematic review and meta-analysis

Author keywords

Alzheimer's disease; meta analyses; systematic review

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

EID: 84901936875     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-132264     Document Type: Review
Times cited : (11)

References (73)
  • 1
    • 33746310315 scopus 로고    scopus 로고
    • Alzheimer's disease
    • DOI 10.1016/S0140-6736(06)69113-7, PII S0140673606691137
    • Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet 368, 387-403. (Pubitemid 44108123)
    • (2006) Lancet , vol.368 , Issue.9533 , pp. 387-403
    • Blennow, K.1    De Leon, M.J.2    Zetterberg, H.3
  • 2
    • 33745027879 scopus 로고    scopus 로고
    • Molecular mechanisms for Alzheimer's disease: Implications for neuroimaging and therapeutics
    • DOI 10.1111/j.1471-4159.2006.03989.x
    • Masters CL, Cappai R, Barnham KJ, Villemagne VL (2006) Molecular mechanisms for Alzheimer's disease: Implications for neuroimaging and therapeutics. J Neurochem 97, 1700- 1725. (Pubitemid 43873662)
    • (2006) Journal of Neurochemistry , vol.97 , Issue.6 , pp. 1700-1725
    • Masters, C.L.1    Cappai, R.2    Barnham, K.J.3    Villemagne, V.L.4
  • 5
    • 0028169925 scopus 로고
    • Visualization of A-42(43) and A-40 in senile plaques with end-specific A- monoclonals: Evidence that an initially deposited species is A-42(43)
    • Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina H, Ihara Y (1994) Visualization of A-42(43) and A-40 in senile plaques with end-specific A- monoclonals: Evidence that an initially deposited species is A-42(43). Neuron 13, 45-53.
    • (1994) Neuron , vol.13 , pp. 45-53
    • Iwatsubo, T.1    Odaka, A.2    Suzuki, N.3    Mizusawa, H.4    Nukina, H.5    Ihara, Y.6
  • 8
    • 0021271971 scopus 로고
    • Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
    • McKhann G, Drachman DA, Folstein M, Katzman R, Price DL, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease - report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944. (Pubitemid 14076461)
    • (1984) Neurology , vol.34 , Issue.7 , pp. 939-944
    • McKhann, G.1    Drachman, D.2    Folstein, M.3
  • 10
    • 0001802176 scopus 로고    scopus 로고
    • Some common problems in medical research
    • 9th ed. Altman DG, ed. Chapman, London
    • Altman DG (1999) Some common problems in medical research. In: Practical Statistics for Medical Research, 9th ed. Altman DG, ed. Chapman, London, pp. 396-439.
    • (1999) Practical Statistics for Medical Research , pp. 396-439
    • Altman, D.G.1
  • 12
    • 24944498883 scopus 로고    scopus 로고
    • Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
    • DOI 10.1016/j.jclinepi.2005.02.022, PII S0895435605001629
    • Reitsma JB, Glas AS, Rutjes AWS, Scholten R, Bossuy PM, Zwinderman AH (2005) Bivariate analysis of sensitivity and specificity produce informative summary measures in diagnostic reviews. J Clin Epidemiol 58, 982-990. (Pubitemid 41316441)
    • (2005) Journal of Clinical Epidemiology , vol.58 , Issue.10 , pp. 982-990
    • Reitsma, J.B.1    Glas, A.S.2    Rutjes, A.W.S.3    Scholten, R.J.P.M.4    Bossuyt, P.M.5    Zwinderman, A.H.6
  • 13
    • 33746630447 scopus 로고    scopus 로고
    • Meta-analysis of diagnostic and screening test accuracy evaluations: Methodologic primer
    • DOI 10.2214/AJR.06.0226
    • Gatsonis C, Paliwal P (2006) Meta-analysis of diagnostic and screening test accuracy evaluations: Methodologic primer. AJR Am J Roentgenol 187, 271-281. (Pubitemid 44148267)
    • (2006) American Journal of Roentgenology , vol.187 , Issue.2 , pp. 271-281
    • Gatsonis, C.1    Paliwal, P.2
  • 14
    • 23644432857 scopus 로고    scopus 로고
    • The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed
    • DOI 10.1016/j.jclinepi.2005.01.016, PII S0895435605001423
    • Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58, 882e93. (Pubitemid 41115772)
    • (2005) Journal of Clinical Epidemiology , vol.58 , Issue.9 , pp. 882-893
    • Deeks, J.J.1    Macaskill, P.2    Irwig, L.3
  • 18
    • 0033061647 scopus 로고    scopus 로고
    • Cerebrospinal fluid -amyloid((1-42)) in Alzheimer disease: Differences between early- and late-onset Alzheimer disease and stability during the course of disease
    • DOI 10.1001/archneur.56.6.673
    • Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K (1999) Cerebrospinal fluid beta-amyloid (1-42) in Alzheimer disease: Differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol 56, 673-680. (Pubitemid 29266465)
    • (1999) Archives of Neurology , vol.56 , Issue.6 , pp. 673-680
    • Andreasen, N.1    Hesse, C.2    Davidsson, P.3    Minthon, L.4    Wallin, A.5    Winblad, B.6    Vanderstichele, H.7    Vanmechelen, E.8    Blennow, K.9
  • 20
    • 0037244487 scopus 로고    scopus 로고
    • Cerebrospinal fluid levels of totaltau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment
    • Andreasen N, Vanmechelen E, Vanderstichele H, Davidsson P, Blennow K (2003) Cerebrospinal fluid levels of totaltau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment. Acta Neurol Scand Suppl 179, 47-51.
    • (2003) Acta Neurol Scand Suppl , vol.179 , pp. 47-51
    • Andreasen, N.1    Vanmechelen, E.2    Vanderstichele, H.3    Davidsson, P.4    Blennow, K.5
  • 26
    • 0142027660 scopus 로고    scopus 로고
    • CSF-tau, CSF-A1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: Combination of CSF-tau and MMSE yields highest sensitivity and specificity
    • DOI 10.1007/s00702-003-0017-7
    • Ganzer S, Arlt S, Schoder V, Buhmann C, Mandelkow EM, Finckh U, Beisiegel U, Naber D, M?uller-Thomsen T (2003) CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: Combination of CSF-tau andMMSEyields highest sensitivity and specificity. J Neural Transm 110, 1149-1160. (Pubitemid 37271858)
    • (2003) Journal of Neural Transmission , vol.110 , Issue.10 , pp. 1149-1160
    • Ganzer, S.1    Arlt, S.2    Schoder, V.3    Buhmann, C.4    Mandelkow, E.-M.5    Finckh, U.6    Beisiegel, U.7    Naber, D.8    Muller-Thomsen, T.9
  • 28
    • 78650464378 scopus 로고    scopus 로고
    • Evaluation of CSF biomarkers as predictors of Alzheimer's disease: A clinical follow-up study of 4.7 years
    • Hertze J, Minthon L, Zetterberg H, Vanmechelen E, Blennow K, Hansson O (2010) Evaluation of CSF biomarkers as predictors of Alzheimer's disease: A clinical follow-up study of 4.7 years. J Alzheimers Dis 21, 1119-1128.
    • (2010) J Alzheimers Dis , vol.21 , pp. 1119-1128
    • Hertze, J.1    Minthon, L.2    Zetterberg, H.3    Vanmechelen, E.4    Blennow, K.5    Hansson, O.6
  • 31
    • 14944376675 scopus 로고    scopus 로고
    • Cerebrospinal fluid TAU protein and amyloid 42 in mild cognitive impairment: Prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination
    • DOI 10.1080/13554790490896901
    • Ivanoiu A, Sindic CJ (2005) Cerebrospinal fluid tau protein and amyloid beta42 in mild cognitive impairment: Prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination. Neurocase 11, 32-39. (Pubitemid 40372858)
    • (2005) Neurocase , vol.11 , Issue.1 , pp. 32-39
    • Ivanoiu, A.1    Sindic, C.J.M.2
  • 34
    • 0037335119 scopus 로고    scopus 로고
    • CSF tau protein and -amyloid (1-42) in Alzheimer's disease diagnosis: Discrimination from normal ageing and other dementias in the Greek population
    • DOI 10.1046/j.1468-1331.2003.00562.x
    • Kapaki E, Paraskevas GP, Zalonis I, Zournas C (2003) CSF tau protein and beta-amyloid (1-42) in Alzheimer's disease diagnosis: Discrimination from normal ageing and other dementias in the Greek population. Eur J Neurol 10, 119-128. (Pubitemid 36308205)
    • (2003) European Journal of Neurology , vol.10 , Issue.2 , pp. 119-128
    • Kapaki, E.1    Paraskevas, G.P.2    Zalonis, I.3    Zournas, C.4
  • 38
    • 67349214609 scopus 로고    scopus 로고
    • Improved discrimination of autopsyconfirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau (181P)
    • Koopman K, Le Bastard N, Martin JJ, Nagels G, De Deyn PP, Engelborghs S (2009) Improved discrimination of autopsyconfirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau (181P). Neurochem Int 55, 214-218.
    • (2009) Neurochem Int , vol.55 , pp. 214-218
    • Koopman, K.1    Le Bastard, N.2    Martin, J.J.3    Nagels, G.4    De Deyn, P.P.5    Engelborghs, S.6
  • 44
    • 25644432885 scopus 로고    scopus 로고
    • 42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration
    • DOI 10.1016/j.jns.2005.05.015, PII S0022510X0500198X
    • Noguchi M, Yoshita M, Matsumoto Y, Ono K, Iwasa K, YamadaM(2005) Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration. J Neurol Sci 15, 61-65. (Pubitemid 41384015)
    • (2005) Journal of the Neurological Sciences , vol.237 , Issue.1-2 , pp. 61-65
    • Noguchi, M.1    Yoshita, M.2    Matsumoto, Y.3    Ono, K.4    Iwasa, K.5    Yamada, M.6
  • 47
    • 70449348828 scopus 로고    scopus 로고
    • Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease
    • Roher AE, Maarouf CL, Sue LI, Hu Y, Wilson J, Beach TG (2009) Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease. Biomarkers 14, 493-501.
    • (2009) Biomarkers , vol.14 , pp. 493-501
    • Roher, A.E.1    Maarouf, C.L.2    Sue, L.I.3    Hu, Y.4    Wilson, J.5    Beach, T.G.6
  • 48
    • 0034942145 scopus 로고    scopus 로고
    • Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients
    • DOI 10.1007/s007020170091
    • R?osler N,Wichart I, JellingerKA(2001) Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients. J Neural Transm 108, 231- 246. (Pubitemid 32695765)
    • (2001) Journal of Neural Transmission , vol.108 , Issue.2 , pp. 231-246
    • Rosler, N.1    Wichart, I.2    Jellinger, K.A.3
  • 53
    • 57349191820 scopus 로고    scopus 로고
    • Interest of CSF beta-amyloid1-42 and t-tau protein level determinations for the diagnosis of Alzheimer's disease
    • Smach MA, Charfeddine B, Lammouchi T, Dridi H, Ben Othman L, Bennamou S, Limem K (2008) Interest of CSF beta-amyloid1-42 and t-tau protein level determinations for the diagnosis of Alzheimer's disease. Ann Biol Clin (Paris) 66, 531-535.
    • (2008) Ann Biol Clin (Paris) , vol.66 , pp. 531-535
    • Ma, S.1    Charfeddine, B.2    Lammouchi, T.3    Dridi, H.4    Ben Othman, L.5    Bennamou, S.6    Limem, K.7
  • 54
    • 0034282184 scopus 로고    scopus 로고
    • Relationship between apoE genotype and CSF beta-amyloid (1-42) and tau in patients with probable and definite Alzheimer's disease
    • Tapiola T, Pirttil?a T, Mehta PD, Alafuzofff I, Lehtovirta M, Soininen H (2000) Relationship between apoE genotype and CSF beta-amyloid (1-42) and tau in patients with probable and definite Alzheimer's disease. Neurobiol Aging 21, 735-740.
    • (2000) Neurobiol Aging , vol.21 , pp. 735-740
    • Tapiola, T.1    Pirttila, T.2    Mehta, P.D.3    Alafuzofff, I.4    Lehtovirta, M.5    Soininen, H.6
  • 55
    • 80054838966 scopus 로고    scopus 로고
    • Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand
    • Thaweepoksomboon J, Senanarong V, Poungvarin N, Chakorn T, Siwasariyanon N, Washirutmangkur L, Udompunthuruk S (2011) Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand. J Med Assoc Thai 94(Suppl 1), S77-S83.
    • (2011) J Med Assoc Thai , vol.94 , Issue.SUPPL. 1
    • Thaweepoksomboon, J.1    Senanarong, V.2    Poungvarin, N.3    Chakorn, T.4    Siwasariyanon, N.5    Washirutmangkur, L.6    Udompunthuruk, S.7
  • 58
    • 77949425172 scopus 로고    scopus 로고
    • Cerebrospinal fluid tau and ptau (181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
    • Fagan AM, Mintun MA, Shah AR, Aldea P, Roe CM, Mach RH, Marcus D, Morris JC, Holtzman DM (2009) Cerebrospinal fluid tau and ptau (181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease.EMBO Mol Med 1, 371-380.
    • (2009) EMBO Mol Med , vol.1 , pp. 371-380
    • Fagan, A.M.1    Ma, M.2    Shah, A.R.3    Aldea, P.4    Roe, C.M.5    Mach, R.H.6    Marcus, D.7    Morris, J.C.8    Holtzman, D.M.9
  • 63
    • 1542313783 scopus 로고    scopus 로고
    • Core biological marker candidates of Alzheimer's disease - Perspectives for diagnosis, prediction of outcome and reflection of biological activity
    • DOI 10.1007/s00702-003-0065-z, Modelling Alzheimers Dementia
    • Hampel H, Mitchell A, Blennow K, Frank RA, Brettschneider S, Weller L, Moller HJ (2004) Core biological marker candidates of Alzheimer's disease-perspectives for diagnosis, prediction of outcome and reflection of biological activity. J Neural Transm 111, 247-272. (Pubitemid 38316604)
    • (2004) Journal of Neural Transmission , vol.111 , Issue.3 , pp. 247-272
    • Hampel, H.1    Mitchell, A.2    Blennow, K.3    Frank, R.A.4    Brettschneider, S.5    Weller, L.6    Moller, H.-J.7
  • 64
    • 77952202260 scopus 로고    scopus 로고
    • CSF biomarkers predict a more malignant outcome in Alzheimer disease
    • Wallin AK, Blennow K, Zetterberg H (2010) CSF biomarkers predict a more malignant outcome in Alzheimer disease. Neurology 74, 1531-1537.
    • (2010) Neurology , vol.74 , pp. 1531-1537
    • Wallin, A.K.1    Blennow, K.2    Zetterberg, H.3
  • 65
    • 0025863618 scopus 로고
    • Neuropathological stageing of Alzheimer-related changes
    • Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
    • (1991) Acta Neuropathol , vol.82 , pp. 239-259
    • Braak, H.1    Braak, E.2
  • 67
    • 0037135111 scopus 로고    scopus 로고
    • The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
    • DOI 10.1126/science.1072994
    • Hardy (2002) the amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
    • (2002) Science , vol.297 , Issue.5580 , pp. 353-356
    • Hardy, J.1    Selkoe, D.J.2
  • 68
    • 84863440187 scopus 로고    scopus 로고
    • Biomarkers in Alzheimer's disease
    • Riverol M, L'opez OL (2011) Biomarkers in Alzheimer's disease. Front Neurol 2, 46.
    • (2011) Front Neurol , vol.2 , pp. 46
    • Riverol, M.1    L'Opez, O.L.2
  • 72
    • 77954706306 scopus 로고    scopus 로고
    • Serial MRI and CSF biomarkers in normal aging, MCI, and -ADSEQ
    • Vemuri (2010) Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology 75, 143-151.
    • (2010) Neurology , vol.75 , pp. 143-151


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.